Prostate Cancer: Three-Dimensional Radiotherapy

CBE ID

0388

1.5 Project

Cancer Endorsement Maintenance

Endorsement Status

Endorsement Removed

1.0 New or Maintenance

Maintenance

1.1 Measure Structure

Single Measure

Previous Endorsement Cycle

Fall 2012

Is Under Review

1.6 Measure Description

Percentage of patients, regardless of age, with a diagnosis of clinically localized prostate cancer receiving external beam radiotherapy as primary therapy to the prostate with or without nodal irradiation (no metastases; no salvage therapy) who receive three-dimensional conformal radiotherapy (3D-CRT) or intensity modulated radiation therapy (IMRT)

Measure Specs

General Information

1.7 Measure Type

Process

1.3 Electronic Clinical Quality Measure (eCQM)

1.8 Level of Analysis

Clinician: Group/Practice

Clinician: Individual

1.9 Care Setting

Ambulatory Care: Clinician Office

Outpatient Services

1.20 Types of Data Sources

Claims Data

Electronic Health Records: Electronic Health Records

Other

Paper Records

Registry data

Point of Contact

Steward Organization

Physician Consortium for Performance Improvement

Steward POC email

Samantha.Tierney@ama-assn.org

Steward Organization Copyright

Physician Performance Measures (Measures) and related data specifications, developed by the Physician Consortium for Performance ImprovementTM (the Consortium), are intended to facilitate quality improvement activities by physicians.
These Measures are intended to assist physicians in enhancing quality of care. Measures are designed for use by any physician who manages the care of a patient for a specific condition or for prevention. These performance Measures are not clinical guidelines and do not establish a standard of medical care. The Consortium has not tested its Measures for all potential applications. The Consortium encourages the testing and evaluation of its Measures.
Measures are subject to review and may be revised or rescinded at any time by the Consortium. The Measures may not be altered without the prior written approval of the Consortium. Measures developed by the Consortium, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and American Medical Association, on behalf of the Consortium. Neither the Consortium nor its members shall be responsible for any use of these Measures.
THE MEASURES ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND
© 2007 American Medical Association. All Rights Reserved
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the Consortium and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
THE SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.

Breadcrumb